Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Weekly Paclitaxel and Gemcitabine in Platinum-Resistant Ovarian Cancer

NCT00003449 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT00003449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Weekly Paclitaxel and Gemcitabine in Platinum-Resistant Ovarian Cancer
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1998
Completion date
February 29, 2004
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer